SCHEMBL19984843

SCHEMBL19984843

COc1cccc(NC(=O)NCc2nnc(-c3cnccn3)o2)c1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 3/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
ALDH1A1 P00352 2/20 0.48
RAB9A P51151 4/20 0.48
PKM P14618 1/20 0.48
MAPK1 P28482 1/20 0.48
TSHR P16473 2/20 0.47
DGAT2 Q96PD7 1/20 0.46
NPC1 O15118 2/20 0.46
MITF O75030 1/20 0.46
ROCK2 O75116 1/20 0.46
LMNA P02545 2/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19984848 0.78 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1RAB9ATSHRNPC1
SCHEMBL14517931 0.73 KDM4E (0.74) SMN1; SMN2ALDH1A1RAB9ATSHRNPC1
SCHEMBL19984978 0.73 TSHR (0.39) SMN1; SMN2ALDH1A1RAB9APKMTSHR
SCHEMBL11615122 0.73 NAMPT (0.83) NAMPTSMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL8176742 0.69 SMN1; SMN2 (0.81) NAMPTSMN1; SMN2RAB9APKMMAPK1
SCHEMBL15573138 0.68 RAF1 (0.74) NAMPTSMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL13480581 0.68 MTNR1B (0.72) SMN1; SMN2ALDH1A1RAB9APKMMAPK1
SCHEMBL4893387 0.67 TP53 (0.87) SMN1; SMN2ALDH1A1RAB9AMAPK1TSHR
SCHEMBL31040569 0.67 TP53 (0.87) SMN1; SMN2ALDH1A1RAB9AMAPK1TSHR
SCHEMBL5756200 0.67 RAB9A (0.77) NAMPTSMN1; SMN2ALDH1A1RAB9APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018051255-A1 CYCLIC SUBSTITUTED-1,3,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2018-03-22 WO disclosed